|
HS Code |
626166 |
| Name | Prosultiamine |
| Chemical Formula | C18H26N4O2S2 |
| Molecular Weight | 410.56 g/mol |
| Synonyms | Alinamin, Thiamine propyl disulfide |
| Drug Class | Vitamin B1 derivative |
| Appearance | White or pale yellow crystalline powder |
| Solubility | Slightly soluble in water |
| Mechanism Of Action | Enhances thiamine absorption and utilization |
| Route Of Administration | Oral |
| Cas Number | 820-26-0 |
As an accredited Prosultiamine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | A white, sealed plastic bottle labeled "Prosultiamine, 100 mg, 100 tablets," featuring hazard symbols and manufacturer information. |
| Shipping | Prosultiamine is shipped in tightly sealed containers, protected from light, moisture, and heat to maintain stability. Packaging complies with chemical transport regulations, including proper labelling and safety documentation. Handling requires gloves and eye protection to prevent exposure. Expedited and temperature-controlled shipping is available upon request to ensure product integrity during transit. |
| Storage | Prosultiamine should be stored in a tightly closed container, protected from light and moisture. Store it at room temperature, ideally between 20°C and 25°C (68°F–77°F). Avoid exposure to excessive heat, humidity, and incompatible substances. Ensure the storage area is well-ventilated and access is restricted to authorized personnel. Follow all relevant safety guidelines for pharmaceutical chemicals. |
|
Purity 98%: Prosultiamine with 98% purity is used in oral nutritional supplements, where it ensures rapid absorption and enhanced bioavailability of thiamine. Melting point 133°C: Prosultiamine with a melting point of 133°C is used in tablet manufacturing, where it provides formulation stability during the compression process. Particle size ≤ 50 µm: Prosultiamine with particle size ≤ 50 µm is used in powdered beverage blends, where it allows for homogeneous mixing and uniform distribution. Stability temperature up to 60°C: Prosultiamine stable up to 60°C is used in liquid formulations, where it maintains potency during storage and transportation. Water solubility 15 mg/mL: Prosultiamine with water solubility of 15 mg/mL is used in injectable preparations, where it enables precise dosage and efficient patient delivery. Molecular weight 437.6 g/mol: Prosultiamine with a molecular weight of 437.6 g/mol is used in pharmacokinetic research studies, where it supports accurate compound tracking and analysis. Low hygroscopicity: Prosultiamine with low hygroscopicity is used in encapsulated products, where it prevents clumping and extends shelf-life. Assay ≥ 98% (HPLC): Prosultiamine with assay ≥ 98% (HPLC) is used in clinical nutrition products, where it guarantees therapeutic consistency and regulatory compliance. |
Competitive Prosultiamine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Sometimes, history hands us familiar answers to complex health problems, and Prosultiamine represents one of those cases. Originally designed in Japan, Prosultiamine traces its roots back to a straightforward need: helping patients overcome vitamin B1 (thiamine) deficiency. Thiamine matters at a fundamental level, playing a central role in energy metabolism and nerve function. Markets around the world have relied on regular thiamine for decades, but not all forms are created equal. Prosultiamine was developed with a clear goal—to handle certain hurdles of absorption that standard thiamine struggles to clear, especially in groups coping with deficiency or specific neurological conditions.
From a practical standpoint, Prosultiamine holds a simple but essential difference. It’s a derivative of thiamine, a chemical cousin made by adding a disulfide group. What this does, in plain terms, is help Prosultiamine slip through cell membranes with less resistance. Compared to regular B1, this structural tweak allows it to work its way into the nervous system easier and stick around in the blood longer. I remember reading about its use in Japan among people with Wernicke-Korsakoff syndrome, a serious neurological condition tied to profound thiamine loss, and noting how quickly physicians there gravitated toward this form of the vitamin, hoping to give patients a fair shot at stability.
The main distinction between Prosultiamine and traditional thiamine comes down to its fat solubility. Regular thiamine depends on water for its ride into tissues, but that poses a problem—our guts don’t always play along, and sometimes absorption stays low. Prosultiamine, on the other hand, operates with a different set of rules. Its molecular adjustments let it dissolve in both water and fat, so it passes much more efficiently through biological barriers, including the blood-brain barrier. Studies suggest that oral Prosultiamine brings higher levels of thiamine into nerve tissues than standard supplements. In real terms, that means patients may see quicker relief from neurological symptoms and steadier, more predictable results.
Many tablets and capsules sold under the Prosultiamine label tend to appear in doses ranging from 50 to 300 mg, tailored to the severity of depletion or doctor's instructions. As with most medications or supplements, it’s wise to follow a physician’s advice rather than guessing. While some folks might try to compare it dose-for-dose with regular thiamine, professionals usually look at outcomes—how quickly it restores nerve health and how well patients tolerate treatment over the long haul.
From personal experience talking to nutritionists and patients, the real value of Prosultiamine often shows up in people dealing with chronic deficiencies that standard thiamine never fully corrects. Alcohol dependence, chronic gastrointestinal diseases, diabetes, and neurodegenerative disorders regularly sap thiamine reserves. Some illnesses directly target the gut, impairing thiamine uptake so much that even large amounts of regular vitamin B1 go to waste. In these cases, switching to Prosultiamine seems to deliver results where other options come up short.
On top of that, Prosultiamine’s stability and absorption rates can sometimes prove vital for those with a higher demand for B1 or those facing surgeries that interfere with gut function. Patients recovering from bariatric surgery, for instance, might rely on it during rehabilitation. The improved bioavailability means less concern about fluctuating nutrient levels, which gives clinics and families a reason to prefer it during those critical periods.
People sometimes ask: What’s wrong with just using standard thiamine hydrochloride or mononitrate? The truth is, there’s nothing “wrong” with older forms—plenty of folks do fine with them, especially for routine supplementation. Yet, in cases of severe depletion or in conditions where absorption gets compromised, these forms often yield spotty results. That’s where more advanced derivatives, like Prosultiamine or benfotiamine, come into the conversation.
Benfotiamine offers another modified thiamine that boasts solid absorption, but its reach into the central nervous system doesn't match Prosultiamine’s. Benfotiamine’s chemistry makes it mainly useful for peripheral tissues, like in diabetes-related nerve pain (peripheral neuropathy). Prosultiamine, in contrast, achieves higher concentrations in the nervous system, so professionals treating complicated neurological cases often place greater trust in its consistency. Colleagues managing rare inborn errors of metabolism sometimes prefer Prosultiamine for that reason, especially when mental status changes rapidly and quick intervention makes a difference.
Clinicians dealing with conditions such as Wernicke’s encephalopathy, Korsakoff’s psychosis, or other neurological complications have long sought options that act swiftly and go where they’re needed most. Prosultiamine’s distinct property—its ability to circulate to the central nervous system in meaningful quantities—has steered its use, especially in some Asian and European hospitals.
I remember one case study discussing dementia linked to chronic low thiamine; the patient, unable to absorb most nutrients by mouth, responded after Prosultiamine replaced standard B1. Both the medical literature and real-world experience point toward its niche: when regular supplements simply don’t cut it, and the stakes are too high for compromise.
Much of the research into Prosultiamine pivots on the idea of bioavailability—the fraction of the nutrient that actually makes it to where it does its work. Thiamine, being water-soluble, often struggles with this hurdle. Digestive changes, certain medications, and chronic diseases all stand in its way. Prosultiamine’s molecular structure—thanks to its disulfide bridge—helps it slip past some of these obstacles, resulting in better uptake and retention. Studies from Japan and Europe have shown that Prosultiamine can raise thiamine levels in the cerebral spinal fluid in ways that older formulations can’t match. For those at risk of life-altering neurological damage from deficiency, this difference could mean the return of mental clarity or prevention of irreversible damage.
Aside from the chemical benefits, daily use of Prosultiamine proves relatively straightforward. Most commonly presented in oral form, some experimental therapies even explore its benefits through infusion, depending on clinical urgency. In true clinical settings, it’s not uncommon to see it prescribed along with other B vitamins to provide a comprehensive safety net for patients with compromised nutrition. Because it acts faster, patients and families might notice subtle improvements in alertness, steadiness, or mood within days, which can become pivotal during challenging recoveries.
No drug or supplement offers absolute safety, and Prosultiamine runs by the same rules. Most healthy individuals tolerate it without much trouble, though mild stomach discomfort may show up in rare cases, a fact echoed by my own conversations with pharmacists and clinicians. Occasionally, high doses have brought about skin rashes or mild allergic reactions. As always, those with known allergies or sensitivities to thiamine compounds should approach with caution, and any new supplement needs close monitoring, especially in people with complex medical backgrounds.
Importantly, Prosultiamine has yet to rack up extensive side effect profiles or severe interactions in the medical literature, but large-scale, long-term studies remain limited outside of Asia. European reviews tend to stress this gap, urging caution and careful follow-up with patients who take it for long periods or alongside multiple medications.
Despite its documented benefits, Prosultiamine hasn’t achieved universal availability. Regulatory approvals remain spotty, depending not just on country but sometimes region. In places with easier access, it forms part of hospital protocols; in others, patients may need to petition doctors for compassionate use or order the product internationally. This patchwork creates a headache for those hoping to standardize care or recommend it as part of a wider nutritional support package.
Some of that comes down to market economics. Vitamins get classified differently than medications, leading to inconsistent oversight. This makes prescribers in some regions more hesitant, since comprehensive risk assessments and long-term data can be hard to come by. That said, Japanese hospitals report steady outcomes in neurological cases over many years, lending some measure of reassurance to those weighing whether the cost and effort of procurement are justified.
Though its reputation rests mainly on neurological uses, Prosultiamine sees experimentation in a range of other clinical settings. HIV research in the early 2000s suggested that it could offer neuroprotective effects for patients with chronic viral infections. Feedback from physicians treating chronic fatigue and diabetes also points to its possible benefits, especially for managing neuropathic symptoms. While precise outcomes are hard to quantify outside clinical trials, many patient advocacy groups keep the discussion alive, hoping for expanded study and access.
Athletes sometimes express curiosity about improved B vitamin absorption, especially those with gruelling training regimens or dietary challenges. Dietitians explain that while regular B1 works for most, those with absorption hurdles—including vegan athletes or aging populations—may get extra mileage out of Prosultiamine. Continued research could clarify its role in supporting long-term nerve health in populations facing slow, subtle depletion from chronic stress or illness.
What strikes me most in patient interviews isn’t just the clinical data but the stories. People coping with chronic nerve pain or sudden cognitive decline sometimes trace real turning points back to when they started Prosultiamine, especially after months or years of frustration with regular supplementation. I once spoke with a family who had seen a relative recover speech and orientation in a matter of weeks, after standard thiamine failed to deliver any change. That’s the kind of outcome that sticks in a provider’s mind and makes them pay attention to new findings or expanded use cases.
Still, anecdotes need the support of rigor and research. It’s reassuring that medical journals and universities in both East Asia and the West have published peer-reviewed studies describing improved neurological function, but most researchers know the importance of guarding against overreach. Given the backdrop of rare but severe diseases like Wernicke-Korsakoff or rapidly progressing neuropathies, the search for better answers continues—and Prosultiamine’s role may well grow in years to come, provided evidence supports expansion.
Access, transparency, and education all remain hurdles. Physicians need better guidelines on how to use Prosultiamine as part of a comprehensive care package, especially for patients with co-existing conditions or those taking multiple supplements. Health systems could benefit from cross-national studies sharing best practices, outcome data, and recommendations for quicker diagnosis of deficiencies—especially where early treatment could prevent irreversible damage. Patients need clear information to distinguish Prosultiamine from “new and improved” claims often attached to vitamins.
It’s also crucial for regulatory agencies to keep pace with changing science. While Prosultiamine’s safety record looks solid, consistent standards and post-market surveillance help catch rare side effects and prevent supplement adulteration. European and Asian case studies, when compiled into networks, allow for real-world data collection across diverse populations.
As demand grows, attention turns toward sourcing and manufacturing quality. Like all supplements and quasi-pharmaceuticals, Prosultiamine’s true benefit depends on consistency—lot by lot, year after year. Independent labs and consumer watchdog groups can help flag impurities or mislabeled products. It’s not enough for manufacturers to claim “premium” or “safe”—routine third-party verification makes the real difference and helps medical professionals feel more confident about recommending Prosultiamine to patients who need it most.
In clinical practice, teams working with hard-to-treat populations—whether facing digestive operations, advanced diabetes, or neurological emergencies—will always look for solutions that offer a margin of safety, speed, and certainty. Prosultiamine’s unique chemistry means it stands out in those situations where every hour or day counts toward preserving quality of life and function.
One of the most important tasks going forward involves clear communication. Clinics, hospitals, and pharmacists should stay up to date on published research, watch for relevant safety updates, and explain the practical differences between Prosultiamine and older thiamine forms. Information should reach patients in terms they understand, avoiding sensational language or unfounded guarantees. In my own conversations with patients, I’ve seen that clear charts, real-life stories, and comparisons with previous experiences make a much bigger impact than technical jargon or marketing gloss. Patients with chronic absorption issues or rare neurological conditions benefit most when practitioners know all available options—including when to escalate care or refer to specialty centers.
As with any innovation in nutritional science or medicine, research takes time to confirm initial impressions. Large, controlled clinical trials remain the gold standard for assessing both effectiveness and risk. Policy makers and academic centers committed to evidence-based practice know that only through ongoing study can Prosultiamine’s precise role be understood, including ideal dosing regimens, long-term safety outcomes, and interactions with other medications or supplements.
Emerging data from university hospitals suggests a growing role for Prosultiamine not just in acute neurological crises but also in long-term management of at-risk populations. Some researchers have pointed to possible applications in Alzheimer’s disease, chronic fatigue syndromes, and systemic inflammatory disorders. Early reports warrant cautious optimism, but more rigorous analysis must guide final recommendations.
In the landscape of vitamin supplementation, Prosultiamine represents something more than just a new pill on the shelf. For those struggling with stubborn or life-threatening thiamine deficiencies, it can offer a genuine path back to health. It’s up to medical professionals, researchers, and policy makers to continue sorting fact from hype, weighing individual tales against population-wide needs. Patients deserve options that work, rooted in both science and lived experience.
Whether Prosultiamine ever becomes a household term or stays a specialized tool, its story reminds us that meaningful progress happens at the intersection of chemistry, clinical expertise, and the daily realities of those managing chronic disease. Staying informed, keeping an open mind, and insisting on quality above all—these shape both personal and public health in this era of expanding dietary and therapeutic choices. Anyone in the medical or wellness field would do well to keep an eye on Prosultiamine, both for what it delivers now and what doors it may open down the road.